Preparation and characterization of cisplatin-incorporated chitosan hydrogels, microparticles, and nanoparticles

被引:29
作者
Cha, Jueun
Lee, Won Bum
Park, Chong Rae [1 ]
Cho, Yong Woo
Ahn, Cheol-Hee
Kwon, Ick Chan
机构
[1] Seoul Natl Univ, Sch Mat Sci & Engn, HOMRC, Enviro Polymers Design Lab, Seoul 151742, South Korea
[2] Hanyang Univ, Dept Chem Engn, Ansan 426791, South Korea
[3] Korea Inst Sci & Technol, Biomed Res Ctr, Seoul 136791, South Korea
关键词
chitosan; platinum; hydrogel; microparticle; nanoparticle; controlled drug release;
D O I
10.1007/BF03218726
中图分类号
O63 [高分子化学(高聚物)];
学科分类号
070305 ; 080501 ; 081704 ;
摘要
Three different, polymer-platinum conjugates (hydrogels, microparticles, and nanoparticles) were synthesized by complexation of cis-dichlorodiammineplatinum(II) (cisplatin) with partially succinylated glycol chitosan (PSGC). Succinic anhydride was used as a linker to introduce cisplatin to glycol chitosan (GC). Succinylation of GC was investigated systematically as a function of the molar ratio of succinic anhydride to glucosamine, the methanol content in the reaction media, and the reaction temperature. By controlling the reaction conditions, water-soluble, partially water-soluble, and hydrogel-forming PSGCs were synthesized, and then conjugated with cisplatin. The complexation of cisplatin with water-soluble PSGC via a ligand exchange reaction of platinum from chloride to the carboxylates induced the formation of nano-sized aggregates in aqueous media. The hydrodynamic diameters of PSGC/cisplatin complex nano-aggregates, as determined by light scattering, were 180-300 run and the critical aggregation concentrations (CACs), as determined by a fluorescence technique using pyrene as a probe, were 20-30 mu g/mL. The conjugation of cisplatin with partially water-soluble PSGC, i.e., borderline between water-soluble and water-insoluble PSGC, produced micro-sized particles < 500 mu m. Cisplatin-complexed PSGC hydrogels were prepared from water-insoluble PSGCs. All of the cisplatin-incorporated, polymer matrices released platinum in a sustained manner without any significant initial burst, suggesting that they may all be useful as slow release systems for cisplatin. The release rate of platinum increased with the morphology changes from hydrogel through microparticle to nanoparticle systems.
引用
收藏
页码:573 / 578
页数:6
相关论文
共 35 条
[1]   PLGA-mPEG nanoparticles of cisplatin: in vitro nanoparticle degradation, in vitro drug release and in Vivo drug residence in blood properties [J].
Avgoustakis, K ;
Beletsi, A ;
Panagi, Z ;
Klepetsanis, P ;
Karydas, AG ;
Ithakissios, DS .
JOURNAL OF CONTROLLED RELEASE, 2002, 79 (1-3) :123-135
[2]   A novel non-toxic camptothecin formulation for cancer chemotherapy [J].
Berrada, M ;
Serreqi, A ;
Dabbarh, F ;
Owusu, A ;
Gupta, A ;
Lehnert, S .
BIOMATERIALS, 2005, 26 (14) :2115-2120
[3]   Metalloproteinase and cytokine production by THP-1 macrophages following exposure to chitosan-DNA nanoparticles [J].
Chellat, F ;
Grandjean-Laquerriere, A ;
Le Naour, R ;
Fernandes, J ;
Yahia, L ;
Guenounou, M ;
Laurent-Maquin, D .
BIOMATERIALS, 2005, 26 (09) :961-970
[4]   The dawning era of polymer therapeutics [J].
Duncan, R .
NATURE REVIEWS DRUG DISCOVERY, 2003, 2 (05) :347-360
[5]   Cisplatin incorporated in microspheres: development and fundamental studies for its clinical application [J].
Fujiyama, J ;
Nakase, Y ;
Osaki, K ;
Sakakura, C ;
Yamagishi, H ;
Hagiwara, A .
JOURNAL OF CONTROLLED RELEASE, 2003, 89 (03) :397-408
[6]   HPMA copolymer platinates as novel antitumour agents:: In vitro properties, pharmacokinetics and antitumour activity in vivo [J].
Gianasi, E ;
Wasil, M ;
Evagorou, EG ;
Keddle, A ;
Wilson, G ;
Duncan, R .
EUROPEAN JOURNAL OF CANCER, 1999, 35 (06) :994-1002
[7]  
Gupta KC, 2000, POLYM INT, V49, P141, DOI 10.1002/(SICI)1097-0126(200002)49:2<141::AID-PI303>3.0.CO
[8]  
2-0
[9]   N-succinyl-chitosan as a drug carrier:: water-insoluble and water-soluble conjugates [J].
Kato, Y ;
Onishi, H ;
Machida, Y .
BIOMATERIALS, 2004, 25 (05) :907-915
[10]   Biological characteristics of lactosaminated N-succinyl-chitosan as a liver-specific drug carrier in mice [J].
Kato, Y ;
Onishi, H ;
Machida, Y .
JOURNAL OF CONTROLLED RELEASE, 2001, 70 (03) :295-307